Dr. Hoil Choi leads Peptron, which brings a robust superiority in drug delivery system industry and demonstrating notable achievements in therapeutic areas such as neurodegenerative diseases, cancer, acromegaly, and metabolic diseases. He found Petron Inc. in 1997 and has over 25 years of experience about peptide research. He began his career with Korea Research Institute of Bioscience & Biotechnology (KRIBB) as a research scientist in 1990. He moved to LG Chemical Co. Ltd where he developed synthesis method and many peptides.
He received his Ph.D. in biochemistry from Yonsei University, Korea and Post-Doc program in Mayo Clinic, USA.
Dr. Seung-Gu Chang has joined in Peptron for 20 years and served as various senior positions across a range of research and finance. In 2006, he was appointed Chief Financial Officer of Peptron and assumed increasing responsibility to secure budget to build our first manufacturing facility and focus on maximizing the return on R&D investment across the Peptron portfolio
Dr. Kyung-duk Moon joined in Peptron 2016 and is managing Project Division across the Peptron R&D portfolio.
He has solid expertise on R&D with various position in his career including research, research managing, R&D strategy development, and execution.
Dr. Joonsik Kim joined in Peptron¡¯s research team in 2006 and he is currently leading whole SR formulation development including manufacturing process development. He focused on development of sustained release formulation in whole his researching periods and also contributed on Peptron¡¯s key patents significantly.
Hyosup Kim joined in Peptron¡¯s Project management Division as Business Development director in 2015. He has almost 20 years of experiences about business development, marketing and sales roles in Pharmaceutical industry with Korean and multi-national companies.